Cooper Companies (NYSE:COO) issued an update on its FY 2019 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $11.30-11.70 for the period, compared to the Thomson Reuters consensus estimate of $12.08. The company issued revenue guidance of $2.6-2.66 billion, compared to the consensus revenue estimate of $2.67 billion.Cooper Companies also updated its FY19 guidance to $11.30-11.70 EPS.
NYSE COO opened at $243.01 on Friday. The company has a debt-to-equity ratio of 0.70, a current ratio of 2.58 and a quick ratio of 1.54. Cooper Companies has a fifty-two week low of $216.47 and a fifty-two week high of $283.18. The firm has a market cap of $13.61 billion, a price-to-earnings ratio of 21.13, a price-to-earnings-growth ratio of 2.13 and a beta of 0.77.
Cooper Companies (NYSE:COO) last released its earnings results on Thursday, December 6th. The medical device company reported $2.87 earnings per share for the quarter, missing the consensus estimate of $2.96 by ($0.09). Cooper Companies had a return on equity of 17.86% and a net margin of 5.52%. The business had revenue of $651.50 million for the quarter, compared to the consensus estimate of $645.25 million. During the same quarter in the previous year, the company earned $2.65 earnings per share. The firm’s revenue for the quarter was up 16.0% on a year-over-year basis. As a group, analysts predict that Cooper Companies will post 12.1 EPS for the current fiscal year.
In other news, VP Randal Golden sold 1,731 shares of the stock in a transaction on Thursday, September 27th. The stock was sold at an average price of $275.86, for a total value of $477,513.66. Following the completion of the transaction, the vice president now directly owns 1,154 shares in the company, valued at approximately $318,342.44. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Allan E. Rubenstein sold 1,500 shares of the stock in a transaction on Thursday, September 13th. The shares were sold at an average price of $265.37, for a total value of $398,055.00. Following the completion of the transaction, the director now owns 3,068 shares of the company’s stock, valued at $814,155.16. The disclosure for this sale can be found here. Insiders sold a total of 20,691 shares of company stock valued at $5,527,869 over the last quarter. 1.60% of the stock is owned by corporate insiders.
COPYRIGHT VIOLATION WARNING: This piece was originally posted by Ticker Report and is the sole property of of Ticker Report. If you are reading this piece on another website, it was illegally copied and reposted in violation of US & international copyright laws. The legal version of this piece can be read at https://www.tickerreport.com/banking-finance/4001150/cooper-companies-coo-releases-fy-2019-earnings-guidance.html.
Cooper Companies Company Profile
The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.
Featured Article: Cost of Capital Explained
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.